Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 157

    1.

    The effect of exercise on the absorption of inhaled human insulin via the AERx insulin diabetes management system in people with type 1 diabetes.

    Petersen AH, Köhler G, Korsatko S, Wutte A, Wonisch M, Jeppesen OK, Sparre T, Clauson P, Laursen T, Wollmer P, Pieber TR.

    Diabetes Care. 2007 Oct;30(10):2571-6. Epub 2007 Jul 9.PMID: 17620446 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of exercise on the absorption of inhaled human insulin in healthy volunteers.

    Petersen AH, Köhler G, Korsatko S, Wutte A, Wonisch M, Mautner A, Rønn BB, Clauson P, Laursen T, Wollmer P, Pieber TR.

    Br J Clin Pharmacol. 2008 Feb;65(2):165-71. Epub 2007 Aug 31.PMID: 17764475 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Dose-response relation of liquid aerosol inhaled insulin in type I diabetic patients.

    Brunner GA, Balent B, Ellmerer M, Schaupp L, Siebenhofer A, Jendle JH, Okikawa J, Pieber TR.

    Diabetologia. 2001 Mar;44(3):305-8.PMID: 11317660 [PubMed - indexed for MEDLINE]Related articles

    4.

    Intensive therapy with inhaled insulin via the AERx insulin diabetes management system: a 12-week proof-of-concept trial in patients with type 2 diabetes.

    Hermansen K, Rönnemaa T, Petersen AH, Bellaire S, Adamson U.

    Diabetes Care. 2004 Jan;27(1):162-7.PMID: 14693983 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.

    Cernea S, Kidron M, Wohlgelernter J, Raz I.

    Clin Ther. 2005 Oct;27(10):1562-70.PMID: 16330292 [PubMed - indexed for MEDLINE]Related articles

    6.

    Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects.

    Henry RR, Mudaliar SR, Howland WC 3rd, Chu N, Kim D, An B, Reinhardt RR.

    Diabetes Care. 2003 Mar;26(3):764-9.PMID: 12610035 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    The impact of smoking on inhaled insulin.

    Himmelmann A, Jendle J, Mellén A, Petersen AH, Dahl UL, Wollmer P.

    Diabetes Care. 2003 Mar;26(3):677-82.PMID: 12610021 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison.

    Henry RR, Mudaliar S, Chu N, Kim D, Armstrong D, Davis TT, An B, Reinhardt RR.

    J Clin Pharmacol. 2003 Nov;43(11):1228-34.PMID: 14551177 [PubMed - indexed for MEDLINE]Related articles

    9.

    Compliance with inhaled insulin treatment using the AERx iDMS Insulin Diabetes Management System.

    Cramer JA, Okikawa J, Bellaire S, Clauson P.

    Diabetes Technol Ther. 2004 Dec;6(6):800-7.PMID: 15684632 [PubMed - indexed for MEDLINE]Related articles

    10.

    Intrasubject variability of inhaled insulin in type 1 diabetes: a comparison with subcutaneous insulin.

    Kapitza C, Hompesch M, Scharling B, Heise T.

    Diabetes Technol Ther. 2004 Aug;6(4):466-72.PMID: 15321001 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of different durations of breath holding after inhalation of insulin using the AERx insulin diabetes management system.

    An B, Reinhardt RR.

    Clin Ther. 2003 Aug;25(8):2233-44.PMID: 14512131 [PubMed - indexed for MEDLINE]Related articles

    12.

    The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin.

    Becker RH, Sha S, Frick AD, Fountaine RJ.

    Diabetes Care. 2006 Feb;29(2):277-82.PMID: 16443873 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Influence of acute upper respiratory tract infection on the absorption of inhaled insulin using the AERx insulin Diabetes Management System.

    McElduff A, Mather LE, Kam PC, Clauson P.

    Br J Clin Pharmacol. 2005 May;59(5):546-51. Erratum in: Br J Clin Pharmacol. 2005 Jul;60(1):114. PMID: 15842553 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes.

    Kim D, Mudaliar S, Chinnapongse S, Chu N, Boies SM, Davis T, Perera AD, Fishman RS, Shapiro DA, Henry R.

    Diabetes Care. 2003 Oct;26(10):2842-7.PMID: 14514589 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Pulmonary insulin administration using the AERx system: physiological and physicochemical factors influencing insulin effectiveness in healthy fasting subjects.

    Farr SJ, McElduff A, Mather LE, Okikawa J, Ward ME, Gonda I, Licko V, Rubsamen RM.

    Diabetes Technol Ther. 2000 Summer;2(2):185-97.PMID: 11469258 [PubMed - indexed for MEDLINE]Related articles

    16.

    Absorption and metabolic effect of inhaled insulin: intrapatient variability after inhalation via the Aerodose insulin inhaler in patients with type 2 diabetes.

    Perera AD, Kapitza C, Nosek L, Fishman RS, Shapiro DA, Heise T, Heinemann L.

    Diabetes Care. 2002 Dec;25(12):2276-81.PMID: 12453973 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Delivering needle-free insulin using AERx iDMS (insulin diabetes management system) technology.

    Wollmer P, Pieber TR, Gall MA, Brunton S.

    Diabetes Technol Ther. 2007 Jun;9 Suppl 1:S57-64.PMID: 17563305 [PubMed - indexed for MEDLINE]Related articles

    18.

    The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.

    Heise T, Bott S, Tusek C, Stephan JA, Kawabata T, Finco-Kent D, Liu C, Krasner A.

    Diabetes Care. 2005 Sep;28(9):2161-9.PMID: 16123484 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Intra-individual variability of the metabolic effect of inhaled insulin together with an absorption enhancer.

    Heinemann L, Klappoth W, Rave K, Hompesch B, Linkeschowa R, Heise T.

    Diabetes Care. 2000 Sep;23(9):1343-7.PMID: 10977030 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro.

    Rave KM, Nosek L, de la Peña A, Seger M, Ernest CS 2nd, Heinemann L, Batycky RP, Muchmore DB.

    Diabetes Care. 2005 Oct;28(10):2400-5.PMID: 16186270 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data